Asensus Surgical Inc (ASXC)
0.2425
0.00 (0.00%)
USD |
NYAM |
May 01, 16:00
0.2425
0.00 (0.00%)
After-Hours: 20:00
Asensus Surgical Cash from Investing (Quarterly): 7.427M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.427M |
| September 30, 2023 | 20.78M |
| June 30, 2023 | 6.564M |
| March 31, 2023 | 29.74M |
| December 31, 2022 | 6.327M |
| September 30, 2022 | 18.04M |
| June 30, 2022 | 0.128M |
| March 31, 2022 | 23.04M |
| December 31, 2021 | -30.60M |
| September 30, 2021 | -88.37M |
| June 30, 2021 | -0.305M |
| March 31, 2021 | -0.395M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.001M |
| March 31, 2020 | -0.002M |
| December 31, 2019 | 15.92M |
| September 30, 2019 | 9.797M |
| June 30, 2019 | 12.94M |
| March 31, 2019 | 28.99M |
| December 31, 2018 | -17.90M |
| September 30, 2018 | -39.75M |
| June 30, 2018 | -0.125M |
| March 31, 2018 | 4.295M |
| December 31, 2017 | 7.415M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.111M |
| June 30, 2017 | -1.294M |
| March 31, 2017 | -0.501M |
| December 31, 2016 | -0.483M |
| September 30, 2016 | -0.361M |
| June 30, 2016 | -0.364M |
| March 31, 2016 | -0.153M |
| December 31, 2015 | -0.506M |
| September 30, 2015 | -25.42M |
| June 30, 2015 | -0.156M |
| March 31, 2015 | -0.155M |
| December 31, 2014 | -0.548M |
| September 30, 2014 | -0.691M |
| June 30, 2014 | 3.746M |
| March 31, 2014 | 1.535M |
| December 31, 2013 | -5.851M |
| September 30, 2013 | -1.373M |
| June 30, 2013 | -0.081M |
| March 31, 2013 | 0.838M |
| December 31, 2012 | 3.558M |
| September 30, 2012 | -4.739M |
| June 30, 2012 | -0.001M |
| March 31, 2012 | -0.005M |
| December 31, 2011 | -0.094M |
| September 30, 2011 | -0.114M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-88.37M
Minimum
Sep 2021
29.74M
Maximum
Mar 2023
1.633M
Average
6.327M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Glaukos Corp | -12.92M |
| Perspective Therapeutics Inc | -0.089M |
| Retractable Technologies Inc | -0.3478M |
| Xtant Medical Holdings Inc | -2.313M |
| Catheter Precision Inc | -0.018M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.37M |
| Cash from Financing (Quarterly) | 0.172M |
| Free Cash Flow | -64.19M |
| Free Cash Flow Per Share (Quarterly) | -0.0508 |
| Free Cash Flow to Equity (Quarterly) | -13.45M |
| Free Cash Flow to Firm (Quarterly) | -13.45M |
| Free Cash Flow Yield | -106.0% |